Accessibility settings

This paper is in the following e-collection/theme issue:

NIH funded proposals with peer-review reports (USA) (204) Neurology and Neurosciences (402) Dementia and Cognitive Decline (928) Pharmacovigilance (258) Longitudinal and Cohort Studies in Public Health (961) Nursing in a Long-Term Care Facility / Nursing Home for the Elderly (84)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64446, first published .
Doctor's hand holding a blister pack of pills over a notepad with a stethoscope

Prescribing Trends and Associated Outcomes of Antiepileptic Drugs and Other Psychotropic Medications in US Nursing Homes: Proposal for a Mixed Methods Investigation

Prescribing Trends and Associated Outcomes of Antiepileptic Drugs and Other Psychotropic Medications in US Nursing Homes: Proposal for a Mixed Methods Investigation

Authors of this article:

Jonathan D Winter1 Author Orcid Image ;   J William Kerns1 Author Orcid Image ;   Nicole Brandt2 Author Orcid Image ;   Linda Wastila2 Author Orcid Image ;   Danya Qato2 Author Orcid Image ;   Roy T Sabo3 Author Orcid Image ;   Stephen Petterson1 Author Orcid Image ;   YoonKyung Chung4 Author Orcid Image ;   Sarah Reves5 Author Orcid Image ;   Christopher Winter1 Author Orcid Image ;   Katherine M Winter1 Author Orcid Image ;   Eposi Elonge2 Author Orcid Image ;   Craig Ewasiuk1 Author Orcid Image ;   Yu-Hua Fu2 Author Orcid Image ;   Adam Funk3 Author Orcid Image ;   Alex Krist1 Author Orcid Image ;   Rebecca Etz5 Author Orcid Image
Article Authors Cited by (2) Tweetations Metrics

Journals

  1. Winter J, Kerns J, Qato D, Wastila L, Winter K, Brandt N, Winter C, Fu Y, Elonge E, Reves S, Bergman C, Krist A, Etz R. A National Survey of Nursing Home Clinicians to Explain Increased Valproate Prescribing. The American Journal of Geriatric Psychiatry 2025;33(11):1197 View
  2. Mtchedlidze T, Sah J, Modebadze G, Javarayee P. Potential savings in Medicaid Antiseizure medication reimbursement, 2008–2025: persistent brand-name reimbursement Despite generic availability. Expert Review of Pharmacoeconomics & Outcomes Research 2026 View